(SBRA) Sabra Healthcare REIT - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US78573L1061
SBRA: Real Estate Properties, Loans, Preferred Equity, Joint Ventures
As of September 30, 2024, Sabra Healthcare REIT Inc. (NASDAQ: SBRA) maintained a diversified portfolio of 373 real estate properties, strategically focused on healthcare-related assets. The portfolio comprised 233 skilled nursing and transitional care facilities, 39 senior housing communities under lease agreements, 68 senior housing communities managed by third-party operators, 18 behavioral health facilities, and 15 specialty hospitals and other healthcare facilities. Additionally, Sabra held 14 investments in loans receivable, including three mortgage loans and 11 other loans, along with five preferred equity investments and two stakes in unconsolidated joint ventures. The properties spanned the United States and Canada, providing 37,793 beds and units, emphasizing Sabras role as a significant player in healthcare real estate.
The companys diversified approach reduces dependency on any single healthcare sector, mitigating risks associated with market fluctuations. Sabras investments in loans receivable and preferred equity further enhance its revenue streams, while joint ventures provide exposure to growth opportunities without full capital commitment. This balanced strategy aligns with Sabras objective of generating stable cash flows and long-term value for shareholders.
Additional Sources for SBRA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SBRA Stock Overview
Market Cap in USD | 4,163m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2002-04-02 |
SBRA Stock Ratings
Growth Rating | 62.3 |
Fundamental | 47.8 |
Dividend Rating | 60.7 |
Rel. Strength | 15.1 |
Analysts | 4.07/5 |
Fair Price Momentum | 19.40 USD |
Fair Price DCF | 28.00 USD |
SBRA Dividends
Dividend Yield 12m | 7.00% |
Yield on Cost 5y | 14.85% |
Annual Growth 5y | -2.33% |
Payout Consistency | 89.7% |
SBRA Growth Ratios
Growth Correlation 3m | 80.3% |
Growth Correlation 12m | 59.5% |
Growth Correlation 5y | 59.1% |
CAGR 5y | 16.87% |
CAGR/Max DD 5y | 0.46 |
Sharpe Ratio 12m | 2.50 |
Alpha | 29.40 |
Beta | 0.301 |
Volatility | 24.43% |
Current Volume | 1878.5k |
Average Volume 20d | 2255k |
As of May 02, 2025, the stock is trading at USD 17.62 with a total of 1,878,544 shares traded.
Over the past week, the price has changed by +0.69%, over one month by +0.69%, over three months by +6.11% and over the past year by +36.26%.
Partly, yes. Based on ValueRay Fundamental Analyses, Sabra Healthcare REIT (NASDAQ:SBRA) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.81 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SBRA as of May 2025 is 19.40. This means that SBRA is currently undervalued and has a potential upside of +10.1% (Margin of Safety).
Sabra Healthcare REIT has received a consensus analysts rating of 4.07. Therefor, it is recommend to buy SBRA.
- Strong Buy: 7
- Buy: 1
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, SBRA Sabra Healthcare REIT will be worth about 21 in May 2026. The stock is currently trading at 17.62. This means that the stock has a potential upside of +18.9%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19.5 | 10.7% |
Analysts Target Price | 19.8 | 12.5% |
ValueRay Target Price | 21 | 18.9% |